featured
Benefit–Risk Profile of P2X3 Receptor Antagonists in the Treatment of Patients With Chronic Cough
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Chest
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Benefit-risk profile of P2X3 receptor antagonists for treatment of chronic cough: Dose-response model-based network meta-analysis
Chest 2024 Jun 08;[EPub Ahead of Print], S Yamamoto, N Horita, J Hara, M Sasamoto, Y Kanemitsu, Y Hara, Y Obase, T Kaneko, A Niimi, H MukaeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.